Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06923657 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy

StatusRecruiting
PhaseNot applicable
Started2025-05-07
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 28, 2026 (before its estimated September 1, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-05-26
Study Status, Oversight v2
Primary completion date2026-05-01→2026-09-01
2025-09-09
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-05-01→confirmed 2025-05-07
Study sitesdetails revised at 1 of 1 site
2025-04-04
Original filing
The goal is to provide more accurate diagnostic tools and optimized diagnostic workflows for clinically suspected prostate cancer patients with prior negative biopsies, improving early detection rates for csPCa and reducing missed diagnoses.
Trial Details
NCT Number NCT06923657
Lead Sponsor First Affiliated Hospital of Fujian Medical University
Conditions Prostate Cancer Screening, PSMA-PET
Enrollment 230 participants
Start Date 2025-05-07
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-28